Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
5-fluorouracil (5-FU)
20%
5-year Survival
40%
Ablative Therapy
20%
Best Response
20%
Carbohydrate Antigen 19-9 (CA19-9)
20%
Chemotherapy
100%
Chronomodulation
20%
Colorectal Cancer Liver Metastasis (CRCLM)
20%
Conventional Chemotherapy
20%
Delayed Diagnosis
20%
Disease-free
20%
Disease-free Survival
20%
Downstaging
20%
Hepatectomy
20%
Hepatic Resection
20%
Initially Unresectable
20%
Irinotecan
20%
Leucovorin
20%
Liver Resection
20%
Liver Surgery
40%
Long-term Survival
100%
Major Hepatectomy
20%
Maximum Size
20%
Maximum Tumor Diameter
20%
Metastasis
20%
Multinodularity
20%
Multivariate Analysis
40%
Number of Metastases
20%
Oxaliplatin
20%
Patient Survival
20%
Portal Embolization
20%
Postoperative Morbidity
20%
Postoperative Mortality
20%
Predictive Model
20%
Preoperative Factors
20%
Preoperative Risk Factors
20%
Preoperative Setting
20%
Primary Liver Resection
20%
Prognostic Factors
40%
Recurrence Rate
20%
Repeat Hepatectomy
40%
Rescue Surgery
100%
Resection
60%
Response to Chemotherapy
20%
Risk Factors
20%
Single Institution
20%
Survival Estimation
20%
Systemic Chemotherapy
20%
Tumor
60%
Tumor Recurrence
20%
Univariate Analysis
20%
Unresectability
20%
Unresectable Colorectal Liver Metastases
100%
Medicine and Dentistry
Ablation Therapy
12%
Chemotherapy
100%
Colorectal Liver Metastasis
100%
Disease Free Survival
12%
Diseases
12%
Embolization
12%
Fluorouracil
12%
Folinic Acid
12%
Hepatectomy
87%
Infusion
12%
Irinotecan
12%
Liver Surgery
25%
Long Term Survival
100%
Metastatic Carcinoma
25%
Morbidity
12%
Multivariate Analysis
25%
Neoplasm
50%
Oxaliplatin
12%
Prognostic Factor
25%
Recurrent Disease
37%
Surgical Mortality
12%
Tumor Recurrence
12%
Univariate Analysis
12%